Introduction {#S0001}
============

*Klebsiella pneumoniae* (*K. pneumoniae*) is a Gram-negative *Enterobacteriaceae* bacterium and the most concerning multidrug-resistant (MDR) pathogen in nosocomial infections.[@CIT0001] Due to MDR and limited treatment choices, *K. pneumoniae* has been associated with a high mortality rate up to 40--50%.[@CIT0002]--[@CIT0006] *K. pneumoniae*, along with other highly important MDR pathogens, has been categorized as ESKAPE *(Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter aumannii, Pseudomonas aeruginosa*, and *Enterobacter* species) organisms.[@CIT0007],[@CIT0008] Many antibiotics, including aminoglycosides, fluoroquinolones, and carbapenems, are used for the treatment of infectious diseases caused by MDR pathogens.[@CIT0009] However, these antibiotics are tremendously threatened by MDR strains of *K. pneumoniae* because they harbor plasmids encoding resistance genes that lead to the increased disease burden.[@CIT0010] The widespread occurrence of these resistance genes highlights the significance of the underlying mechanism that needs to be elucidated.

A bacterial strain can transfer its antibiotic-resistant traits either horizontally or vertically to its filial generations or act as a donor for mobile genetic elements (MGEs) for instance plasmids and transposons. MGEs are the main effective vehicles for antibiotic resistance horizontal transfer from one bacterial strain to other strains, species, or genera.[@CIT0011],[@CIT0012] Among all kinds of MGEs, plasmids play a key role in gene transfer processes.[@CIT0013],[@CIT0014] *K. pneumoniae* acquired resistance through the successful acquisition of MDR plasmids, including those classified into IncFII, IncFIIY, IncHI2, and IncX1, incompatibility groups.[@CIT0015]--[@CIT0017] Plasmids harboring antimicrobial resistance markers in clinical strains are a severe threat to public health worldwide.

In the present study, three MDR plasmids pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA* isolated from *K. pneumoniae* strain A1705, 911021, and 1642, respectively, were sequenced. Each of pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA* harbored two different replication initiation genes *repA* (IncFIB-family) and *repB1* of an unknown incompatibility group. Initially, *repA* and *repB1* were found in pKPN-c22 (GenBank AC\# CP009879.1) isolated from *K. pneumoniae*. Until now, total nine fully sequenced plasmids carrying *repA* and *repB1* have been reported including pKPN-c22, pKPN3-307_typeA (GenBank AC\# KY271404.1), pKPN3-307_TypeC (GenBank AC\# KY271406.1), p6234-198.371kb (GenBank AC\# CP010390.1) and pKPSH11 (GenBank AC\# KT896504.1), pKPN3-307_typeD (GenBank AC\# accession number: KY271407),[@CIT0018] pCN1_1 (GenBank AC\#CP015383), pRJ119-NDM1 (GenBank AC\# KX636095),[@CIT0019] and pKP301cro (GenBank AC\# KY495890) isolated from *K. pneumoniae* (last accessed, 26 October 2017). However, among these plasmids, not a single one has been assigned to any incompatibility group. Although, the detailed structures of IncFIB plasmids carrying *repA, repB1* have not been characterized and genomic comparison of this incompatibility group has not been performed.

The current study provides a deep understanding concerning structural genomics of pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA* and five other sequenced plasmids carrying *repA, repB1* with the highest homology provide further insights into the incompatibility (FIB) group. The common features and differences of their backbone regions and accessory modules are extensively analyzed and elaborated. The detailed genomic characterization of MDR plasmids will contribute to improve the diagnostics and understand the epidemiological relevance of *Klebsiella* strains.

Materials and Methods {#S0002}
=====================

Bacterial Strains and Identification {#S0002-S2001}
------------------------------------

*K. pneumoniae* A1705 and 911021 strains were isolated from the urine samples of patients attending teaching hospitals in Shenyang and Chongqing, respectively. *K. pneumoniae* 1642 was isolated from a bronchoalveolar lavage fluid of a patient in the 307^th^ Hospital of the People's Liberation Army in Beijing. Bacterial species were identified by the VITEK-2 automated system (BioMerieux Inc., Marcy-l'Etoile, France) and 16S rRNA gene sequencing.[@CIT0020] The multilocus sequence typing (MLST) scheme for *K. pneumoniae* was followed as mentioned on the homepage ([<http://bigsdb.pasteur.fr/klebsiella>]{.ul})[@CIT0003] by utilizing seven housekeeping genes (*gapA, infB, mdh, pgi, phoE, rpoB*, and *tonB*).[@CIT0021] PCR screening of ESBLs,[@CIT0022] carbapenem resistance,[@CIT0023] quinolone resistance,[@CIT0024] macrolide resistance[@CIT0025] and common tetracycline resistance genes[@CIT0026] was carried out for each strain. All PCR amplicons were sequenced on an ABI 3730 platform (Applied Biosystems, CA, USA).

Plasmid Transfer {#S0002-S2002}
----------------

Plasmid conjugal transfer was carried out by *K. pneumoniae* strains A1705, 911021, 1642 as donors and *E.coli* DH5α as the recipient. Overnight cultures of both strains (3mL), recipient and donor bacteria, were grown, mixed together and then harvested. The mixed culture was resuspended in 80ul of brain-heart infusion broth (BD Biosciences, CA, USA). The mixture was put onto a filter membrane of about 1 cm^2^, subsequently placed onto a plate containing brain-heart infusion agar (BD Biosciences) and subsequently incubated at 37°C for mating for 12--18 h. The bacterial culture washed from the filter membrane and spread onto Mueller-Hinton (MH) agar (BD Biosciences) plates which had 4 µg/mL ciprofloxacin and 4 µg/mL tetracycline for the screening of trans-conjugants.[@CIT0027] As successful conjugation was not achieved, so electroporation experiments were carried out using *K. pneumonia* A1705, 911021, 1642 as the donor and *E.coli* DH5α as the recipient. The 2µL of plasmid DNA solution was added in 50 µL of *E.coli* DH5α and the cell suspension was transferred into ice-cooled electroporation cuvette followed by electroporation using a single pulse at the highest setting, corresponding to, 25 µF, 200 Ω, and 2.5 kV. After an electric shock, the cell suspension was diluted immediately by adding 1 mL volume of Super Optimal Broth (SOB) liquid medium and incubated for 1 hour at 37°C in a shaker at 220 rpm/min. An appropriate amount of suspension was applied to the resistant plate and incubated overnight at 37°C. Bacterial growth was re-enriched on the new resistant plate by picking up single isolated colonies. The transformation was confirmed by selection in ciprofloxacin 4ug/mL; (A1705) or tetracycline 4ug/mL (911021 and 1642) containing medium and plasmids.[@CIT0028],[@CIT0029]

Antimicrobial Susceptibility Test {#S0002-S2003}
---------------------------------

Antimicrobial susceptibility to ampicillin, compound sulfamethoxazole, ciprofloxacin, levofloxacin, aztreonam, ceftazidime, piperacillin, cefazolin, cefuroxime, cefuroxime axetil, ceftriaxone, gentamicin, cefotetan, cefepime, imipenem, meropenem, nitrofurantoin, piperacillin/tazobactam, and amikacin was tested by broth dilution method and the minimum inhibitory concentration values were interpreted according to the Clinical and Laboratory Standards Institute (CLSI, 2015) guidelines.[@CIT0027],[@CIT0030]

Sequencing and Sequence Assembly {#S0002-S2004}
--------------------------------

Genomic DNA was extracted from each of the A1705, 911021, and 1642 isolates using a QIAGEN Blood & Cell Culture DNA Maxi Kit (Qiagen, Hilden, Germany). Genomic sequencing of A1705 and 911021 isolates was performed using a Single-MoleculeReal-Time technique on a PacBio RSII sequencer (Pacific Biosciences, CA, USA). Contigs were assembled using SMARTdenovo1.0 ([<https://github.com/ruanjue/smartdenovo>]{.ul}).

Genomic DNA of the 1642 isolate was sequenced from a mate-pair library with an average insert size of 5000 bp, using a MiSeq sequencer (Illumina, CA, USA). Reads were trimmed to remove the poor quality sequences,[@CIT0031] afterwards the contigs were congregated using Newbler 3.0.[@CIT0032] Gaps among contigs were bridged by utilizing a combination of PCR and Sanger sequencing using an ABI 3730 Sequencer (Applied Biosystems).

Sequence Annotation and Comparison {#S0002-S2005}
----------------------------------

Open reading frames (ORFs) and pseudogenes were predicted using RAST server[@CIT0033] combined with BLASTP/BLASTN[@CIT0034] results against UniProtKB/Swiss-Prot[@CIT0035] and RefSeq databases.[@CIT0036] Annotation of resistance genes, mobile elements, and other features were performed using online databases including ISfinder,[@CIT0037] ResFinder,[@CIT0038] and INTEGRALL.[@CIT0039] Gene organization diagrams were drawn in Inkscape 0.48.1 ([<https://inkscape.org/en/>]{.ul}).

GenBank Accession Numbers {#S0002-S2006}
-------------------------

The complete sequences of pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA* were submitted to GenBank under the accession numbers MG764551, MG288679, and MF156696, respectively.

Results {#S0003}
=======

Characterization of *K. pneumoniae* Strains {#S0003-S2001}
-------------------------------------------

*K. pneumoniae* strains A1705 and 911021 were assigned to sequence type 449 and 11, respectively, while 1642 was given a new sequence type 2040, as determined by MLST. PCR screening confirmed the presence of *bla*~KPC-2~, *bla*~NDM-1~, *bla*~OXA-1~, *qnrS1, oqxAB, tetA*(A), *tetA*(D), *bla*~CTX-M-14~, *bla*~CTX-M-15~, *bla*~TEM-1,~ and *bla*~SHV-33~ genes in *K. pneumoniae* strain A1705 while the presence of the *bla*~KPC-2~, *qnrS1, oqxAB, mph*(A), *tetA*(A), *bla*~CTX-M-14~, *bla*~CTX-M-65~, *bla*~SHV-11,~ and *bla*~TEM-1~ genes in *K. pneumoniae* strain 911021 and the presence of *bla*~KPC-2~, *qnrS1, mph*(A), *tetA*(A), *bla*~TEM-1~, *bla*~CTX-M-65~, *bla*~SHV-12,~ *bla*~CTX-M-14~ genes in *K. pneumoniae* strain 1642. Later, three common drug resistance genes *qnrS1, tetA*(A), and *bla~CTX-M-14~* were co-transferred from *K. pneumoniae* strains A1705, 911021, 1642 into *E.coli* DH5α through electroporation, generating the transformants A1705-*qnrS*-DH5α, 911021-*tetA*-DH5α, and 1642-*tetA*-DH5α respectively. These results demonstrated the existence of these genes in all three plasmids of our study.

Antibiotic resistant *K. pneumoniae* strains (A1705, 911021, and 1642) and their respective transformants, were found to be resistant against ampicillin, ampicillin/sulbactam, compound sulfamethoxazole, piperacillin, cefazolin, cefuroxime, cefuroxime axetil, ceftriaxone, and gentamicin. Additionally, these strains also exhibited resistance against cefotetan, cefepime, nitrofurantoin, aztreonam, meropenem, imipenem, ceftazidime, piperacillin/tazobactam, levofloxacin, and ciprofloxacin. It also has been observed that 911021 and 1642 strains were resistant against amikacin, but strain A1705 was sensitive to amikacin ([Table 1](#T0001){ref-type="table"}).Table 1Antimicrobial Drug Susceptibility ProfilesCategoryAntibioticsMIC (mg/L)/Antimicrobial SusceptibilityA17059110211642A1705-qnrS- DH5α911021-tetA- DH5α1642-tetA- DH5αDH5αPenicillinsAmpicillin≥32/R≥32/R≥32/R≥32/R≥32/R≥32/R≤2/RPiperacillin≥128/R≥128/R≥128/R≥128/R≥128/R≥128/R≤4/SPiperacillin/tazobactam≥128/R≥128/R≥128/R≤4/S≤4/S≤4/S≤4/SCephalosporinsCefazolin≥64/R≥64/R≥64/R≥64/R≥64/R≥64/R≤4/SCefuroxime≥64/R≥64/R≥64/R≥64/R≥64/R≥64/R=4/SCefuroxime axetil≥64/R≥64/R≥64/R≥64/R≥64/R≥64/R=4/SCefotetan≥64/R≥64/R≥64/R≤4/S≤4/S≤4/S≤4/SCeftazidime≥64/R=32/R≥64/R≤1/S≤1/S=16/R≤1/SCeftriaxone≥64/R≥64/R≥64/R=32/R≥64/R≥64/R≤1/SCefepime≥64/R≥64/R≥64/R≤1/S≤1/S≤1/S≤1/SMonobactamAztreonam≥64/R≥64/R≥64/R=4/S=4/S≥64/R≤1/SCarbapenemsImipenem≥16/R≥16/R≥16/R≤1/S≤1/S≤1/S≤1/SMeropenem≥16/R≥16/R≥16/R≤0.25/S≤0.25/S≤0.25/S≤0.25/SAminoglycosidesAmikacin≤2/S≥64/R≥64/R≤2/S≤2/S≤2/S≤2/SGentamicin≥16/R≥16/R≥16/R≥16/R≥16/R≥16/R≤1/SFluoroquinolonesCiprofloxacin≥4/R≥4/R≥4/R=2/I=0.5/S=0.5/S≤0.25/SLevofloxacin≥8/R≥8/R≥8/R=1/S=1/S=1/S≤0.25/SFuraneNitrofurantoin=128/R≥512/R≥512/R≤16/S≤16/S≤16/S≤16/SSulfanilamidesCompound sulfamethoxazole≥320/R≥320/R≥320/R≥320/R≤20/R≤20/R≤20/R[^2]

Overview of Plasmids pA1705-*qnrS*, P911021-*tetA*, and P1642-*tetA* {#S0003-S2002}
--------------------------------------------------------------------

Clinical isolates of *K. pneumoniae* strains A1705, 911021, 1642 were resistant to β-lactams (including carbapenems), quinolones and carried *qnrS1, tetA*(A), *bla~CTX-M-14~* plasmid-borne resistance genes. Considering this, we have chosen these isolates for further genome sequencing and detailed plasmid sequence analysis.

Genome sequencing demonstrated that pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA* are circular DNA sequences of 271, 255bp, 238, 681bp, 237, 591bp and the average GC contents are 51.89%, 51.69%, 51.77%, annotated with 335, 301, 300 predicted ORFs, respectively ([[Supplementary Figure 1](http://www.dovepress.com/get_supplementary_file.php?f=228704.docx)]{.ul} and [Table 2](#T0002){ref-type="table"}). The pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA* carry two replicons, an IncFIB-type of 1011-bp *repA* (replication initiator) gene and 1014-bp *repB1* belong to unknown incompatibility group. These plasmids contain an IncFIB-type *repA* gene, so these are referred to as the IncFIB group.Table 2Major Features of Plasmids AnalyzedCategoryPlasmidspA1705-qnrSp911021-tetAp1642-tetApKPN-c22pKPSH11pKPN3-307_TypeCpKPN3-307_TypeAp6234-198.371kbCountryShenyang Shengjing, ChinaChongqing, ChinaBeijing, ChinaUSAShafdan, IsraelItalyItalyColombia, USAIsolation sourceurine sampleurine samplealveolar lavage fluidurine sampleMunicipal waterBody fluidBody fluidBody fluidHost bacterium*Klebsiella pneumoniaeKlebsiella pneumoniaeKlebsiella pneumoniaeKlebsiella pneumoniaeKlebsiella pneumoniaeKlebsiella pneumoniaeKlebsiella pneumoniaeKlebsiella pneumoniae*Collection dateApril, 2013August, 2014August, 20142013Oct, 2015201420142012Total length (bp)271,255 bp238,681 bp237,591 bp178,563 bp186,474 bp212,319 bp227,989 bp198,371 bpMean G+C content, %51.89%51.69%51.77%51.5%51.5%52.4%52.2%51.6%Total number of ORF335301300303342303356349[^3][^4]

In current research, a linear genomic comparison was performed with eight plasmids including (pKPN-c22 \[first discovered plasmid, harboring *repA* and *repB1*\] as the reference plasmid, pA1705-*qnrS*, p911021-*tetA*, p1642-*tetA* \[three plasmids of this study\], pKPN3-307_typeA, pKPN3-307_TypeC, p6234-198.371kb, and pKPSH11) which showed the highest sequence homology to each of these three plasmids and shared replication genes ([[Supplementary Table S1](http://www.dovepress.com/get_supplementary_file.php?f=228704.pdf)]{.ul}). The molecular structure of each plasmid was divided into the conserved backbones, and a large number of separate accessory modules ([Figure 1](#F0001){ref-type="fig"}).Figure 1Linear comparison of the sequenced plasmid.**Notes:** A linear comparison of the group of plasmids namely pKPN-c22, pKPSH11, p6234-198.371k, pKPN3-307_TypeC, pKPN3-307_typeA, pA1705-*qnrS*, p911021-*tetA* and p1642-*tetA* was performed containing the replication initiation genes *repA* and the *repB1*. Genes are indicated by arrows; genes, moving elements, and other regions are represented by different colors by function; shaded parts indicate regional nucleotide identity is greater than 95%.

The conserved backbones comprising plasmid replication (*repA* and *repB1*), plasmid maintenance, and conjugal transfer regions. Plasmid maintenance region contained *umuCD, parAB* and the *parB*'s binding sites *parC* \[copy number varied among plasmids (9, 9, 11, 4, 11, 9, 9, 4 for pKPN-c22, pKPSH11, p6234-198.371kb, pKPN3-307_TypeC, pKPN3-307_typeA, pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA*, respectively)\] of the 43-bp tandem repeat (gcaGatAAcCTgAcCgAcGAtGCAGGTGGGACCGTGGTCcCAG) were found in these plasmids, a capital letter represents the base for all copies as the same and a lower letter differing bases between the copies. The conjugal transfer region composed of *finO*, a set of F-type conjugative DNA transfer genes including *rlx, dtr, cpl, sfx, eex, tivF* (*tivF1* to *tivF16, tivF18*, and *tivF19), traJQ*, and *trbEF* ([[Supplementary Figure 1](http://www.dovepress.com/get_supplementary_file.php?f=228704.docx)]{.ul}).

Backbone Regions of Plasmids {#S0003-S2003}
----------------------------

Pairwise comparison analyses showed that eight plasmids had \>96% nucleotide identity across\>77% of their backbone sequences ([[Supplementary Table S2](http://www.dovepress.com/get_supplementary_file.php?f=228704.pdf)]{.ul}). However, there were three major differences among the backbones of these eight plasmids: First, compared with pKPN-c22, the translocation of two separate regions (orf*414*-orf*162* and orf*2340*-orf*543*) occurred in pKPSH11. Second the deletion of these two separate regions was found in pKPN3-307_TypeC, pKPN3-307_typeA, pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA*. Third, nine modular differences were found in the conjugal transfer region. These differences are i): the gene *finO* was truncated in the plasmid pKPN3-307_TypeC, pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA*; ii): the gene *tivF3* was interrupted into two parts, namely *ΔtivF3 −5ʹ* and *ΔtivF3-3ʹ* in the plasmid pKPN-c22; iii): the gene *tivF13* was truncated in the plasmid pKPN-c22; iv): the gene *sfx* was truncated in the plasmids pKPN3-307_typeA, pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA*; v): the gene *rlx* was interrupted into three fragments in the plasmid pKPN3-307_TypeC; vi): the gene *traQ* was truncated in the plasmid pKPN3-307_TypeC; vii): the gene *tivF12* was interrupted in two parts, *ΔtivF12-5ʹ* and *ΔtivF12-3ʹ* in the plasmid pKPN3-307_TypeC; viii): the gene *tivF18* was truncated in the plasmids pKPN3-307_TypeC, pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA*; ix): the gene *tivF16* was truncated in plasmids pA1705-*qnrS*, p911021-*tetA*, and p1642-*tetA* ([Figure 1](#F0001){ref-type="fig"}).

Accessory Regions {#S0003-S2004}
-----------------

Many different accessory modules were integrated at various sites within the backbones of these eight analyzed plasmids ([Figure 1](#F0001){ref-type="fig"}; [Table 3](#T0003){ref-type="table"}). The IS*903B*, IS*1X1*--IS*Ecl1*, ΔIS*1X1*--ΔIS*Kpn25*, CHASRI, IS*1G*--IS*Sen4*, and MDR were found common in the all analyzed plasmids with slight differences. Notably, all these eight plasmids harbored resistance genes; all of which were located in the MDR regions ([Table 4](#T0004){ref-type="table"}). MDR region from pKPN-c22, pKPSH11, p6234-198.371kb, pKPN3-307_TypeC, and pKPN3-307_typeA, and the MDR-1 region from pA1705-*qnrS* has a complex mosaic structure and is sequentially organized ([Figure 2](#F0002){ref-type="fig"} and [[Supplementary Table S3](http://www.dovepress.com/get_supplementary_file.php?f=228704.pdf)]{.ul}) while the MDR regions from p1642-*tetA* and p911021-*tetA*, and the MDR-2 from pA1705-*qnrS* shared similar structure with slight variations ([Figure 3](#F0003){ref-type="fig"} and [[Supplementary Table S4](http://www.dovepress.com/get_supplementary_file.php?f=228704.pdf)]{.ul}).Table 3Accessory Modules of Plasmids AnalyzedpKPN-c22pKPSH11p6234-198.371kbpKPN3-307_TypeCpKPN3-307_typeApA1705-qnrSp911021-tetAp1642-tetAIS*903B*IS*903B*IS*903B*ΔIS*903B*IS*903B*IS*903B*IS*903B*IS*903B*IS*1X1*--IS*Ecl1*--ΔIS*1X1*--ΔIS*Kpn25*IS*1X1*--IS*Ecl1*IS*1X1*--IS*Ecl1*--ΔIS*1X1*--ΔIS*Kpn25*ΔIS*1X1*--IS*Ecl1*--IS*1X1*-ΔIS*Kpn25*IS*1X1*--IS*Ecl1*--ΔIS*1X1*--ΔIS*Kpn25*IS*1X1*--IS*Ecl1*--ΔIS*1X1*--ΔIS*Kpn25*IS*1X1*--IS*Ecl1*--ΔIS*1X1*--ΔIS*Kpn25*IS*1X1*--IS*Ecl1*--ΔIS*1X1*--ΔIS*Kpn25*CHASRIIS*Kpn28*CHASRICHASRICHASRICHASRICHASRICHASRI*ars*-1 seatΔIS*1X1*--ΔIS*Kpn25ars*-1 seat*ars*-1 seat*ars*-1 seatIS*Ec52*IS*Ec52*IS*Ec52*IS*26*CHASRIIS*26*ΔIS*Kpn38*ΔIS*Kpn38ars*-2 seat*ars*-2 seat*ars*-2 seatDecentralized and functionally unkown areas*ars*-1 seatDecentralized and functionally unkown areasΔIS*1X3*ΔIS*1X3*MDR-1IS*26*--ΔIS*26*--IS*5075*--IS*Kpn24* residualIS*26*--IS*5075*MDR regionΔIS*26*--ΔIS*26*,MDR regionUrea ABCDE operonUrea ABCDE operonΔIS*1X3fecABCDE*operonMDR regionIS*Ec21*Decentralized and functionally unkown areasIS*Kpn28*--IS*Kpn28*ΔIS*Raq1*--IS*5* family transposase--IS*5075*--IS*Kpn24* residualΔIS*Raq1*--IS*5* family transposase--IS*5075*--IS*Kpn24* residualUrea ABCDE operonIS*Ec6*2 residualGlutathione ABC transfer systemIS*903D*MDR regionIS*1G*--IS*Sen4fecABCDE* operon*fecABCDE*operonΔIS*Raq1*--IS*5 family transposase*--IS*5075*Glutathione ABC transfer systemIS*Ec6*2 residualIS*903D*IS*1G*--IS*Sen4*--IS*Ec6*2 residualIS*Ec6*2 residualMDR-2MDR region*fecABCDE*operonIS*Kpn28*----Glutathione ABC transfer systemGlutathione ABC transfer systemGlutathione ABC transfer systemIS*5075*IS*Kpn24* residual--IS*5075*IS*1G*--IS*Sen4*----IS*5075*IS*5075*IS*Ec6*2 residual*Lac* seat*Lac* seat------*Lac* seat*Lac* seat*fecABCDE* operonIS*1A*IS*1A*------IS*1G*IS*1G*IS*Kpn24* residual--IS*5075*Decentralized and functionally unkown areasDecentralized and functionally unkown areas------Glycogen synthesis clusterGlycogen synthesis cluster*Lac* seatIS*Raq1*IS*Raq1*------Decentralized and functionally unkown areasΔIS*903B*--IS*1X1*IS*1A*IS*1G*--IS*Sen4*IS*1G*--IS*Sen4*------MDR regionDecentralized and functionally unkown areasDecentralized and functionally unkown areas----------IS*1G*--IS*Sen4*MDR regionIS*Raq1*----------IS*1G*--IS*Sen4*IS*1G*--IS*Sen4*---- Table 4Drug Resistance Genes in Plasmids AnalyzedPlasmidResistance GeneResistance PhenotypeNucleotide PositionRegion LocatedpKPN-c22*catB3*Phenicol resistance62,051.62494The MDR region*bla~OXA-1~*β-Lactam resistance62,632.63507*aacA4cr*Aminoglycoside resistance63,593.64192*tetA(A)*Tetracycline resistance66,136.67335*qnrB1*Quinolone resistance75,563.76207*dfrA14*Trimethoprim resistance79,066.79548pKPSH11*sul2*Sulfonamide resistance79,409.80224The MDR region*strA*Aminoglycoside resistance80,285.81088*strB*Aminoglycoside resistance81,088.81942*bla~TEM-1~*β-Lactam resistance82,645.83505*bla~CTX-M-15~*β-Lactam resistance86,327.87202*tmrB*Tunicamycin resistance96,444.96986*aacC2*Aminoglycoside resistance96,999.97859*catB3*Phenicol resistance98,093.98641*bla~OXA-1~*β-Lactam resistance98,779.99654*aacA4cr*Aminoglycoside resistance99,740.100339*qnrB1*Quinolone resistance112,046.112690*dfrA14*Trimethoprim resistance115,412.115894p6234-198.371kb*Sul2*Sulfonamide resistance66,393.67208The MDR region*strA*Aminoglycoside resistance67,269.68072*strB*Aminoglycoside resistance68,072.68908*bla~CTX-M-15~*β-Lactam resistance73,311.74186*tmrB*Tunicamycin resistance88,190.88732*aacC2*Aminoglycoside resistance88,745.89605*catB3*Phenicol resistance90,362.90910*bla~OXA-1~*β-lactam resistance91,048.91923*aacA4cr*Aminoglycoside resistance92,009.92608*tetA(A)*Tetracycline resistance96,063.97262*qnrB1*Quinolone resistance106,318.106962*dfrA14*Trimethoprim resistance110,153.110635pKPN3-307_typeA*Sul2*Sulfonamide resistance129,146.129961The MDR region*strA*Aminoglycoside resistance130,022.130825*strB*Aminoglycoside resistance130,825.131661*bla~TEM-1~*β-actam resistance132,382.133242*bla~CTX-M-15~*β-Lactam resistance136,064.136939*tmrB*Tunicamycin resistance141,538.142080*aacC2*Aminoglycoside resistance142,093.142953*aacA4cr*Quinolone resistance143,863.144462*bla~OXA-1~*β-lactam resistance144,548.145423*catB3*Phenicol resistance145,561.146019*qnrB1*Quinolone resistance153,364.154008*dfrA14*Trimethoprim resistance157,291.157773pKPN3-307_TypeC*aacA4cr*Quinolone resistance124,667.125266The MDR region*bla~OXA-1~*β-Lactam resistance125,352.126227*catB3*Phenicol resistance126,365.126913*tetA(A)*Tetracycline resistance129,467.130666*qnrB1*Quinolone resistance138,855.139499*dfrA14*Trimethoprim resistance142,791.143264pA1705-*qnrS*(MDR-1)*bla~TEM-1~*β-Lactam resistance71,817.72677*strB*Aminoglycoside resistance72,942.73778*strA*Aminoglycoside resistance73,778.74581*sul2*Sulfonamide resistance74,642.75457*tetA(D)*Tetracycline resistance79,032.80216pA1705-*qnrS*(MDR-2)*tetA(A)*Tetracycline resistance124,510.125709The MDR region*dfrA1*Trimethoprim resistance126,942.127415*qnrS1*Quninolone resistance139,821.140477*bla~LAP-2~*β-Lactam resistance142,074.142931*tmrB*Tunicamycin resistance147,263.147805*aacC2*Aminoglycoside resistance147,818.148678*bla~CTX-M-14~*β-Lactam resistance158,542.159393p911021-*tetAbla~CTX-M-14~*β-Lactam resistance90,093.90944The MDR region*aacC2*Aminoglycoside resistance100,783.101643*tmrB*Tunicamycin resistance101,656.101643*bla~LAP-2~*β-Lactam resistance106,530.107387*qnrS1*Quninolone resistance108,984.109640*aphA1a*Aminoglycoside resistance116,481.117296*mph(A)*Macrolide resistance118,273.119178*dfrA1*Trimethoprim resistance125,273.125746*tetA(A)*Tetracycline resistance126,979.128178p1642-*tetAtetA(A)*Tetracycline resistance88,527.89726The MDR region*dfrA1*Trimethoprim resistance90,959.91432*mph(A)*Macrolide resistance97,527.98432*bla~SHV-12~*β-Lactam resistance100,242.101102*qnrS1*Quninolone resistance107,773.108429*bla~LAP-2~*β-actam resistance110,026.110883*tmrB*Tunicamycin resistance115,215.115757*aacC2*Aminoglycoside resistance115,770.116630*bla~CTX-M-14~*β-Lactam resistance125,112.125963 Figure 2Accessory modules of the MDR region from pKPN-c22, pKPSH11, p6234-198.371kb, pKPN3-307_TypeC, and pKPN13-307_typeA and the MDR-1 region from pA1705-*qnrS*.**Notes:** Genes are indicated by arrows; genes, moving elements, and other regions are represented by different colors by function; shaded parts indicate regional nucleotide identity greater than 95%.Figure 3Accessory modules of the MDR region from p1642-*tetA* and p911021-*tetA*, and the MDR-2 region from pA1705-*qnrS*.**Notes:** Genes are indicated by arrows; genes, moving elements, and other regions are represented by different colors by function; shaded parts indicate regional nucleotide identity is greater than 95%.

### In191, In37 from pKPSH11/P6234-198.371kb/pKPN3-307_typeA/pKPN3-307_TypeC and pKPN-C22 {#S0003-S2004-S3001}

The prototype Tn*402*-associated class 1 integron was typically divided sequentially into IRi (inverted repeat at the integrase end), the *5ʹ*-conserved segment (*5ʹ*-CS: *intI1*\[integrase\]--*attI1* \[IntI1-recognizing recombination site\]), the gene cassette array, the *3ʹ*-conserved segment (*3ʹ*-CS: *qacE1* \[quaternary ammonium compound resistance\]--*sul1* \[sulfonamide resistance\]--*orf5--orf6*), the Tn*402tni* module (*tniABQR*) and IRt (inverted repeat at the *tni* end), bounded by *5ʹ*-bp DRs. In191 from the MDR region of pKPSH11/p6234-198.371kb/pKPN3-307_typeA was derived from the prototype Tn*402*-associated class 1 integron. In191 had IRi, 5ʹ-CS, a single-gene (*dfrA14*) cassette (trimethoprim resistance), *mobC*--IRt--IS*6100*, IRt with the loss of 3ʹ-conserved segment (*3ʹ*-CS: Δ*qacEΔ1*--*sul1*--*orf5*--*orf6*) and *tni*, bounded by 5-bp DRs. In comparison with prototype Tn402-associated class 1 integron, the In191 in pKPN-c22 had undergone the loss of IRi, while the truncation at the 3ʹ-end of *mobC*, IS*6100* and the loss IRt occurred within In191 from pKPN3-307_TypeC ([Figure 2](#F0002){ref-type="fig"}).

A complex class 1 integron, In37 was surrounded by terminal 5-bp DRs and included IRi, 5ʹ-CS, variable region 1 (VR1:*aacA4cr* \[aminoglycoside resistance\]--*bla*~OXA-1~ \[β-lactam resistance\]--*catB3* \[phenicol resistance\]--*arr3* \[rifampin resistance\]), the first copy of 3ʹ-conserved segment (3ʹ-CS1: Δ*qacEΔ1*\[quaternary ammonium compound resistance\]--*sul1*\[sulfonamide resistance\]), IS*CR1*, variable region 2 (VR2: *qnrA1*--ampR), the truncation of the second copy of 3ʹ-conserved segment (Δ3ʹ-CS2: Δ*qacEΔ1*--*sul1*--*orf5*--*orf6*), IRt (inverted repeat at the *tni* end), IS*6100* replacing the Tn*402tni* module and IRt. In pKPN3-307_typeA/pKPN3-307_TypeC, In37 had undergone the segmentation into a remnant (*aacA4cr*--*bla*~OXA-1~--Δ*catB3*), which was inverted compared with that in pKPN-c22/pKPSH11/p6234-198.371kb ([Figure 2](#F0002){ref-type="fig"}).

### Tn*2* and the Truncated IS*26-tetA*(D)-*tetR*(D)-IS*26* Unit from MDR-1 Region of pA1705-*qnrS* {#S0003-S2004-S3002}

Tn*2*, a Tn*3*-family transposon was flanked by 5-bp DRs and showed the following modular structure: IRL--*tnpA*--*res*(resolution site)--*tnpR*(resolvase)--*bla*~TEM-1~ (penicillin resistance)--IRR.[@CIT0040] pKPN-c22 carried a 2645-bp Tn*2* segment (IRL--Δ*tnpA*), that was also found in p6234-198.371kb, but at the opposite orientation. An intact Tn*2* was identified in the MDR-1 region from pA1705-*qnrS*, while the Tn*2* had undergone disintegration to form two parts, namely Tn*2*-5ʹ, Tn*2*-3ʹ in pKPSH11 and p6234-198.371kb. In pKPN3-307_typeA, ΔTn*2* (identical to Tn*2*-3ʹ from pKPSH11/p6234-198.371kb) and the Tn*2* remnant (Δ*tnpA*) were identified ([Figure 2](#F0002){ref-type="fig"}).

The IS*26-tetA*(D)-*tetR*(D)-IS*26* unit \[also designated Tn*tet*(D)\], derivative of the tetracycline resistance unit, was made up of two directly oriented IS*26* elements flanking a central region that contained *orf435, adh, tetA*(D) (tetracycline efflux protein), and *tetR*(D) (tetracycline repressor protein).[@CIT0041] The truncated IS*26-tetA*(D)-*tetR*(D)-IS*26* unit found in MDR-1 region of pA1705-*qnrS* comprised *adh, tetA*(D), and *tetR*(D) with IS26 on both sides ([Figure 2](#F0002){ref-type="fig"}).

### Tn*5403* from P6234-198.371kb and pKPN3-307_TypeC {#S0003-S2004-S3003}

Tn*5403*, a Tn*3* family unit transposon with typical 38-bp IRs at both ends, was first found in a *K. pneumoniae* strain and displayed the structure *tnpA*--*tnpR*.[@CIT0042] Tn*5403* was intact in pKPN-c22, pKPSH11, and pKPN3-307_typeA, but has been found in fragmented forms; Tn*5403*-5ʹ and Tn*5403*-3ʹ in p6234-198.371kb and had undergone the loss of IRR_Tn*5403* and a 5-bp truncation of *tnpR* at the 3ʹ-end in pKPN3-307_TypeC ([Figure 2](#F0002){ref-type="fig"}).

### Tn*1721* Remnant and Unit IS*3000*--*qnrB1*--IS*26* from pKPN-C22, pKPSH11, P6234-198.371kb, and pKPN3-307_TypeC, pKPN3-307_typeA {#S0003-S2004-S3004}

The tetracycline resistance gene of hybridization class A \[*tet*(A)\] is associated with non-conjugative transposon Tn*1721*. Gram-negative bacteria obtained mobilizable plasmids from different sources having complete or truncated variants of Tn*1721*.[@CIT0043] Tn*1721* is a member of Tn*21* subgroup of Tn*3*-family unit bacterial transposons[@CIT0044] having three 38 bp inverted repeats, with the following modular structure: IRR--*mcp*(methyl-accepting chemotaxis protein)--*res* (resolution site)--*tnpR*(resolvase)--*tnpA*(transposase)--IRL-1--*tetR*(A)--*tetA*(A)--*pecM*(PecM-like protein)--*tnpA*--IRL-2. Tn*1721* consisted of a "basic transposon," Tn*1722*, which was cryptic, with the modular structure IRR--*tnpAR*--*mcp*--IRL. The *tetR*(A)--*tetA*(A)--*pecM* module remained same in each of pKPN-c22, pKPSH11, p6234-198.371kb, and pKPN3-307_TypeC, while in pKPN3-307_typeA, only a small segment of Δ*tnpA* (transposase) was discovered ([Figure 2](#F0002){ref-type="fig"}).

The IS*3000*--*qnrB1*--IS*26* unit, a *qnrB1* transmission vehicle, was first found in pPKPN1 from PittNDM01.[@CIT0045] The *pspF*--*qnrB1*--Δ*orf909* was bracketed by two different ISs, namely IS*3000* and IS*26*. In each of pKPN-c22, pKPSH11, p6234-198.371kb, pKPN3-307_typeA, and pKPN3-307_TypeC, the IS*3000* within this unit was truncated at the 5ʹ-terminal due to the transposition of Tn*5403*. The Δ*orf909* was truncated in pKPN-c22/pKPSH11/p6234-198.371kb, while in pKPSH11, IS*26* was truncated as well ([Figure 2](#F0002){ref-type="fig"}).

### Tn*6415* from pKPN3-307_typeA and pKPSH11 {#S0003-S2004-S3005}

Tn*6415*, first appraised in plasmid unitig_2 (GenBank accession number CP021536) from *Escherichia coli* strain AR_0119, was an IS*26*-flanked composite transposon. It was bracketed by 8-bp DRs and arranged in the following order: IS*26, aacC2* (aminoglycoside resistance), *tmrB* (tunicamycin resistance), *orf222, orf891*, and IS*26*. Tn*6415* had undergone the deletion of DRs in pKPN3-307_typeA, the truncation upstream of right-hand IS*26* in p6234-198.371kb and further truncation at the 5ʹ-end of the right-hand IS*26*, 3ʹ-end of left-hand IS*26* in pKPSH11 ([Figure 2](#F0002){ref-type="fig"}).

### IS*26-Cld*-IS*26* Unit in pKPN-C22, P6234-198.371kb, and pKPSH11 {#S0003-S2004-S3006}

In previous studies, genomic analyses suggested that chlorite dismutase originates in the perchlorate respiratory islands, from which it is transferred into transposons in the chlorate respirers. The *cld* gene behaves like a rogue and is predicted as a result of horizontal gene transfer.[@CIT0046] We found IS*26-cld*-IS*26* unit carrying *cld* (chlorite dismutase) and some genes of unknown function, encircled by two directly orientated IS*26* elements. In pKPN-c22, a 38-bp deletion was observed at the 5ʹ-end of *orf1083*. In p6234-198.371kb, the left-hand IS*26* within this unit was truncated, while in pKPSH11, the left-hand IS*26* was further truncated, and the truncation of IS*26* in *orf384* at the right-hand was discovered ([Figure 2](#F0002){ref-type="fig"}).

### Tn*5393c* and IS*26*--*Sul2*--*strA*--*strB*--IS*26* Unit from pA1705-*qnrS*, pKPSH11, P6234-198.371kb and pKPN3-307_typeA {#S0003-S2004-S3007}

Tn*5393c*, an active transposon, containing *strA*--*strB* was reported for the first time in the family of Tn*5393*.[@CIT0047] It showed the modular structure as follows; *tnpA-res-tnpR-strA-strB* with direct and inverted repeats at both ends. The IS*26*--*sul2*--*strA*--*strB*--IS*26* unit was an IS*26*-flanked transposition unit and first discovered in pK245 from *K. pneumoniae* strain NK245.[@CIT0048] It was comprised of remnant (*strA*--*strB*--IRR_Tn*5393c*) of the Tn*5393* family unit transposon Tn*5393c*, the upstream *sul2*, and the downstream *orf411*--*orf738*--*orf684*--IS*26*. In pA1705-*qnrS*, this unit had undergone segmentation into two parts of different lengths (1478 and 3152 bp) resulting from the insertion of an intact Tn*2*. Only a 3607-bp remnant (*sul2*--*strA*--*strB*--IRR_Tn*5393c*--*orf411*) was observed in pKPSH11/p6234-198.371kb/pKPN3-307_typeA ([Figure 2](#F0002){ref-type="fig"}).

### In*363*, Tn*1721* Remnant and IS*26-bla*~SHV-12~-IS*26* Unit from P1642-*tetA*/P911021-*tetA* and pA1705-*qnrS* {#S0003-S2004-S3008}

In*363*, a *dfrA1* gene and a gene array of undefined function was classified in class 1 integrons.[@CIT0049] We observed the In*363* from the MDR region of p1642-*tetA*/p911021-*tetA* and found that it was similar to the prototype Tn*402*-associated class 1 integron. In*363* had Δ5ʹ-CS (Δ*intI1*--*attI1*), GCA (*dfrA1* \[trimethoprim resistance\]--*gcuC* \[unknown function\]), *3ʹ*-CS and IRt. Compared with the prototype Tn*402*-associated class 1 integron, In*363* has gone through the truncation of *intI1*, the loss of IRi and *tni*. The In*363* in the MDR-2 region of pA1705-*qnrS* have been found to be inserted with IS*Kpn26* ([Figure 3](#F0003){ref-type="fig"}).

In plasmids pA1705-*qnrS*, p1642-*tetA*, and p911021-*tetA*, Tn*1721* have been dislocated into two fragments, namely the Tn*1721* remnant (IRL_Tn*1721*--Δ*mcp*) and ΔTn*1721*\[*tetR*(A)--*tetA*(A)--*pecM*--Δ*tnpA*--IRR-2_Tn*1721*\]. The 5-bp DRs are locating upstream of the Tn*1721* remnant and downstream of ΔTn*1721* indicate that the disruption occurred after transposition. Remarkably, the lengths of the Tn*1721* remnants varied among plasmids (1455-, 1601-, and 1707-bp for p1642-*tetA*, MDR-2 pA1705-*qnrS*, and p911021-*tetA* respectively) ([Figure 3](#F0003){ref-type="fig"}).

IS*26-bla*~SHV-12~-IS*26* locus was found in different genetic environments, including class 1 integrons and transposons.[@CIT0050] These elements could play an important role in the spread of *bla*~SHV-12~ and are suggestive of multiple recombination events. IS*26-bla*~SHV-12~-IS*26* carried *bla*~SHV-12~--*deoR-yjbJ*--*yjbK*--*yjbL*--*yjbM* genes, encircled by IS*26* at both ends. Two fragments (IS*26*--*bla*~SHV-12~--*deoR* and *yjbJ*--*yjbK*--*yjbL*--*yjbM*--IS*26*) were identified in the opposite direction in p1642-*tetA*. Nonetheless, a single portion (Δ*deoR*--*yjbJ*--*yjbK*--*yjbL*--Δ*yjbM*) of the IS*26-bla*~SHV-12~-IS*26* unit was found in pA1705*qnrS*/p911021-*tetA* ([Figure 3](#F0003){ref-type="fig"}).

### IS26*-mph(A)--mrx--mphR(A)*--IS6100, IS26-*bla*~LAP~-2--*qnrS*-IS26 and *aacC2--tmrB* Transposition Units from P1642-*tetA*/P911021-*tetA* and pA1705-*qnrS* {#S0003-S2004-S3009}

The IS*6100* transposable unit is based on IS*26*, IS*6100* and includes *mph*(*A*)*--mrx--mphR*(*A*) operon.[@CIT0051] The insertion sequences IS*26* and IS*6100* belong to the IS*6* family, contain almost identical IRs of 14 bp in length. The complete IS*26*--*mph*(*A*)*--mrx--mphR*(*A*)--IS*6100* transposable unit appears in plasmid p1642-*tetA*/p911021-*tetA*, but only a small residue was found in plasmid pA1705-*qnrS* ([Figure 3](#F0003){ref-type="fig"}).

The IS*26-bla~LAP-2~--qnrS*-IS*26* transposition unit was first discovered in plasmid pE66An in *E. coli* E66An (AC \# HF545433). The transposable unit structure is IS*26, ftsI, bla~LAP-2~, orf657*, ΔIS*Ecl2, qnrS1, ΔtnpR*, IS*Kpn19*, and IS*26*. The unit lost its IS*26* at its right-hand end in plasmids p1642-*tetA*, pA1705-*qnrS*, and p911021-*tetA* ([Figure 3](#F0003){ref-type="fig"}).

Furthermore, The complete *aacC2--tmrB* transposition unit was found in at least 13 plasmids, including plasmid pEl1573 in *Enterobacter cloacae* El1573.[@CIT0052] The structure of the *aacC2-tmrB* unit is IS*26*, Tn*2* residual, *aacC2, tmrB*, orf192, *orf228, orf1158*, IS*Cfr1*, and Tn*2* residues. There is only a small portion (*aacC2--tmrB*--*orf192--orf228*--*Δorf1158*) of this unit that was found in each p1642-*tetA*, pA1705-*qnrS*, and p911021-*tetA* ([Figure 3](#F0003){ref-type="fig"}).

Discussion {#S0004}
==========

Antibiotics such as aminoglycosides, β-lactams, quinolones and macrolides, consumption have been spread globally, but the emergence of MDR *K. pneumoniae* often lead to the failure of clinical antibiotics. It is important to distinguish and elucidate the drug resistance genes in plasmid and genetic environment, thereby illustrating the drug resistance mechanism mediated by MDR plasmids. There are many mechanisms involved in *K. pneumoniae* resistance to multiple antibiotics, among those, horizontal transfer of resistance genes is the most significant.

All of the eight analyzed plasmids from environmental and clinical isolates belonging to *K. pneumoniae* were obtained from different countries including China, USA, Italy, and Israel. The transferability of plasmids through conjugation was still unsuccessful due to the lack of some conjugal transfer genes even after the repetitive attempts of plasmid transformation. However, the mobility of plasmids was verified by the transformation experiments. The findings showed that pA1705-*qnrS*, p911021-*tetA, and* p1642-*tetA* could be transferred from *K. pneumoniae* strains A1705, 911021, 1642 into A1705-*qnrS*-DH5α, 911021-*tetA*-DH5α, and 1642-*tetA*-DH5α through electroporation. Although conjugation is necessary for plasmid maintenance, it has been found that compensatory adaptation plays a possible role in plasmid stability by eliminating the plasmid carriage cost together with positive selection for antibiotic resistance. Compensatory adaptation is sufficient to maintain the plasmid stability and possibly explain the reasons behind the existence of non-conjugative plasmids.[@CIT0053] Bacteria become resistant by picking up such MDR plasmids carrying resistance genes.

The comparison of pKPN-c22 (reference plasmid) backbone structure and other plasmids demonstrate genetic conservation in terms of gene contents and organization even omitting the deletion and inversion of some segments. Interestingly, backbones of plasmids could integrate a large number of accessory modules, mostly integrated at one "hotspot", located between *orf312* and *repB1*. It is interesting that the insertion of MDR regions occurs at the same site in the backbone of all plasmids, but occasionally with the insertion of two MDR regions. It is worth determining whether there are specific mechanisms associated with this incompatibility group plasmid that promote their involvement in the complex processes of acquisition of foreign genetic material.

The distribution of antibiotic resistance genes, particularly multidrug resistance genes, via transposable elements is an important concerning issue globally. In the current study, we found that pKPN-c22, pA1705-*qnrS*, p911021-*tetA*, p1642-*tetA*, pKPN3-307_typeA, pKPN3-307_TypeC, p6234-198.371kb, and pKPSH11 resistant plasmids encompass genes that are involved in resistance against seven different classes of antibiotics including aminoglycosides, quinolones, sulfonamides, tetracycline, trimethoprim, tunicamycin, phenicol, and macrolides. Notably, the presence of redundant resistance genes formed highly resistant strains A1705, 911021, and 1642 correspond to the classes of antibiotics, including aminoglycosides (*aacC2*), quinolones (*qnrB1*), sulfonamides (*sul2*), and macrolides (*mph*(A)). This resistance limits the selection of antibiotics for the therapies of infections caused by these bacterial strains.

As the acquisition of multiple-resistance genes is associated with a variety of mobile elements, such as insertion sequences, integrons (In*363*, In*37*, In*191*) and transposons (Tn*4352*, Tn*1721*, Tn*6415*, Tn*2*) which mediate the gene transfer events. The presence of mobile elements containing antibiotic resistance genes is a concern since it can promote the dissemination of resistance. This study also demonstrated the various truncated versions of mobile elements that carried the multiple resistance genes. These findings could explain the evolution of these eight plasmids through complex transposition and homologous recombination events.

Conclusion {#S0005}
==========

Comparative genomic analysis of non-conjugative, *repA, repB1*-carrying plasmids pA1705-*qnrS*, p911021-*tetA*, p1642-*tetA* were carried out to determine the structural insights of these plasmids. The backbone regions of IncFIB plasmids are small as compared to the accessory regions, and the accessory regions are composed of a large number of mobile elements. Multidrug resistance mediated through these MGE's, which contained the resistant genes, among *K. pneumoniae* strains. Stable inheritance and replication of these plasmids are promoted by the coordination of replicons with maintenance gene sets and the conjugation regions. This study provides a detailed genetic characterization of IncFIB plasmids, an important route for horizontal transfer of the resistance genes through mobile elements among IncFIB-family plasmids. Additionally, current findings provided a primary cause of *Enterobacteriaceae* epidemiology, especially MDR *K. pneumoniae*. The prevalence of resistant IncFIB plasmids carrying *repA* and *repB1* at various geographic areas is still required to determined from clinical settings cultures especially those from immuno-compromised patients. Moreover, the identification and evaluation of specific factors and underlying mechanisms associated in the spread of these resistant plasmids also needs to be elucidated. There is still extensive experimental, clinical, and Bioinformatics techniques are required to reduce the dissemination of virulence and antimicrobial resistant plasmids in hospital settings. Furthermore, epidemiological studies and regular inspection of *repA* and *repB1*-carrying IncFIB plasmids will be of great importance.
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